Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (MEDXF)

Medexus Pharmaceuticals Inc (MEDXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022

Results include first U.S. revenue from Gleolan, full commercial launch expected in fiscal Q2 Treosulfan NDA resubmitted to the FDA, regulatory...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus Schedules First Quarter 2023 Conference Call

TORONTO and CHICAGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Treosulfan NDA Resubmitted to FDA

FDA decision expected within six months of acceptancePivotal phase 3 clinical trial of treosulfan met primary endpoint and key secondary endpoints TORONTO...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus Generates Revenue of US$76.7 Million in Fiscal Year 2022 and US$20.3 million in Fiscal Q4 (Strongest Q4 Revenue in Company History)

Management to host conference call at 8:00 AM Eastern Time on Thursday, June 23, 2022...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call

TORONTO and CHICAGO, June 14, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Treosulfan Pivotal Study Results Published

Study’s primary endpoint and key secondary endpoints were met Study found event-free survival and overall survival superior after treosulfan compared to...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus Pharmaceuticals Provides Update on Resubmission of Treosulfan NDA

TORONTO and CHICAGO, May 24, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) has been informed by medac, a strategic...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA

Additional data collection and analysis reconfirms confidence in New Drug Application for TreosulfanNDA resubmission date consistent with previously...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus to Present at the Bloom Burton & Co. Healthcare Investor Conference

TORONTO and CHICAGO, April 19, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) will be presenting at the Bloom...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)
Medexus to Participate in the 34th Annual Roth Conference

TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to...

MDP.TO : 3.00 (unch)
MEDXF : 2.3950 (+1.91%)

Barchart Exclusives

Looking At An HD Earnings Iron Condor For Next Week
Home Depot is sitting right in between the 50 and 200 day moving averages. Traders that think the stock might stay within that range over earnings could look at an iron condor. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar